Skip to main content

Keudell/Morrison Wealth Management

Position in NVS — Novartis AG

CIK 1785498 Salem, OR

Position in NVS

as of Jun 30, 2026 · filed Jul 15, 2026
Position Value
$322,529
+$8,170 QoQ
Shares Held
2,058
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#1,090
of 1,603 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Keudell/Morrison Wealth Management holds $22,085,611 across 13 Drug Manufacturers - General names. NVS ranks #13 (1.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NVS

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $322,529 2,058
2026-03-31 $314,359 2,058
2025-12-31 $276,842 2,008
2025-06-30 $342,216 2,828
2025-03-31 $315,265 2,828
2024-12-31 $265,072 2,724
2024-09-30 $312,509 2,717
2024-06-30 $297,129 2,791
2024-03-31 $282,161 2,917
2023-12-31 $318,863 3,158
2023-09-30 $320,044 3,142
2023-06-30 $320,994 3,181
2023-03-31 $301,668 3,279
2022-12-31 $297,470 3,279
2022-09-30 $256,077 3,369
2022-06-30 $271,003 3,206
2022-03-31 $361,354 4,118
2021-12-31 $331,598 3,791
2021-09-30 $322,785 3,947
2021-06-30 $335,671 3,679
2021-03-31 $299,180 3,500
2020-12-31 $326,444 3,457
2020-09-30 $305,577 3,514
2020-06-30 $333,900 3,823
2020-03-31 $262,191 3,180